Shares of Intellia Therapeutics ( NASDAQ: NTLA) rose 6% after Citizens JMP Securities upgraded the stock from Market Perform to Market Outperform with a new $33 price target, citing a strengthened ...

Citizens JMP analyst Jonathan Wolleben raised the firm’s price target on Ocular Therapeutix (OCUL) to $29 from $20 and keeps an Outperform rating ...

CyberArk Software Ltd. (NASDAQ:CYBR) is one of the Buzzing AI Stocks on Wall Street. On September 23, Citizens JMP analyst ...

Detailed price information for Cyberark Soft Ord (CYBR-Q) from The Globe and Mail including charting and trades.

Fintel reports that on September 23, 2025, JMP Securities downgraded their outlook for CyberArk Software (NasdaqGS:CYBR) from ...

Investing.com - JMP Securities maintained its Market Outperform rating and $4.00 price target on Esperion Therapeutics (NASDAQ:ESPR) after the company’s partner received regulatory approval in Japan.

The Senior Community Service Employment Program (SCSEP), run by the Department of Labor, was established by Congress in 1965 to provide grants to states and national nonprofit organizations, helping ...

JMP statistical software Mac delivers powerful data analysis and dynamic visualization tools tailored for macOS. Explore data deeply, discover hidden patterns. JMP Statistical Software for Mac is a ...

In a report released today, Andrew Boone from Citizens JMP reiterated a Buy rating on Unity Software, with a price target of $35.00. The company’s shares closed yesterday at $43.10. Take advantage of ...

Investing.com - JMP Securities maintained its Market Outperform rating and $35.00 price target on Unity Software (NYSE:U) on Thursday. The company has shown remarkable momentum, with a 191.4% return ...